In these studies, endothelin A receptor (ETAR) antagonists were found to reduce proliferation and restore apoptosis in various cancer cell lines, including prostate, cervical and ovarian cancers and leukemia cells [15–19]. Here, EDNRA is linked to ovarian cancer.